Technical Analysis for RGEN - Repligen Corporation

Grade Last Price % Change Price Change
grade A 68.86 2.73% 1.83
RGEN closed up 2.73 percent on Friday, May 24, 2019, on 1.18 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical RGEN trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Fell Below 20 DMA Bearish 2.73%
Bollinger Band Squeeze Range Contraction 2.73%
BB Squeeze Started Range Contraction 2.73%
NR7 Range Contraction 0.50%
Inside Day Range Contraction 0.50%

Older signals for RGEN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Repligen Corporation, a life sciences company, engages in the development, production, and commercialization of consumable products used in the process of manufacturing biological drugs. Its bioprocessing products are sold to various life sciences and biopharmaceutical companies worldwide. The company manufactures Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. It also supplies various growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, the company develops and markets its OPUS brand series of pre-packed ‘plug-and-play' chromatography columns, and provides ELISA test kits to ensure final product quality. Further, Repligen has a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and a orphan drug candidate in Phase 1 development. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Natural Sciences Consumable Products Monoclonal Antibody Bioprocessing
Is RGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 71.21
52 Week Low 42.8
Average Volume 390,562
200-Day Moving Average 58.2363
50-Day Moving Average 62.0418
20-Day Moving Average 67.959
10-Day Moving Average 68.02
Average True Range 2.6894
ADX 23.39
+DI 26.9678
-DI 17.1915
Chandelier Exit (Long, 3 ATRs ) 63.14179999999999
Chandelier Exit (Short, 3 ATRs ) 63.5082
Upper Bollinger Band 70.2615
Lower Bollinger Band 65.6565
Percent B (%b) 0.7
BandWidth 6.776144
MACD Line 1.8997
MACD Signal Line 2.2111
MACD Histogram -0.3114
Fundamentals Value
Market Cap 2.57 Billion
Num Shares 37.3 Million
EPS 0.51
Price-to-Earnings (P/E) Ratio 135.02
Price-to-Sales 12.40
Price-to-Book 6.72
PEG Ratio 2.55
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 73.18
Resistance 3 (R3) 73.22 71.82 72.46
Resistance 2 (R2) 71.82 70.72 71.80 72.22
Resistance 1 (R1) 70.34 70.04 71.08 70.30 71.98
Pivot Point 68.94 68.94 69.31 68.92 68.94
Support 1 (S1) 67.46 67.84 68.20 67.42 65.74
Support 2 (S2) 66.06 67.16 66.04 65.50
Support 3 (S3) 64.58 66.06 65.26
Support 4 (S4) 64.54